Abstract
Heterotrimeric G proteins are molecular switches that control signal transduction, and their dysregulation can promote oncogenesis. Somatic mutations in GNAS, GNAI2 and GNAQ genes induce oncogenesis by rendering Gα subunits constitutively activated. Recently the first somatic mutation, arginine243 → histidine (R243H) in the GNAO1 (Gαo) gene was identified in breast carcinomas and shown to promote oncogenic transformation when introduced into cells. Here, we provide the molecular basis for the oncogenic properties of the Gαo R243H mutant. Using limited proteolysis assays, nucleotide-binding assays, and single-turnover and steady-state GTPase assays, we demonstrate that the oncogenic R234H mutation renders Gαo constitutively active by accelerating the rate of nucleotide exchange; however, this mutation does not affect Gαo's ability to become deactivated by GTPase-activating proteins (GAPs) or by its intrinsic GTPase activity. This mechanism differs from that of previously reported oncogenic mutations that impair GTPase activity and GAP sensitivity without affecting nucleotide exchange. The constitutively active Gαo R243H mutant also enhances Src-STAT3 signaling in NIH-3T3 cells, a pathway previously shown to be directly triggered by active Gαo proteins to promote cellular transformation. Based on structural analyses, we propose that the enhanced rate of nucleotide exchange in Gαo R243H results from loss of the highly conserved electrostatic interaction of R243 with E43, located in the in the P-loop that represents the binding site for the α- and β-phosphates of the nucleotide. We conclude that the novel R234H mutation imparts oncogenic properties to Gαo by accelerating nucleotide exchange and rendering it constitutively active, thereby enhancing signaling pathways, for example, src-STAT3, responsible for neoplastic transformation.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Barren B, Natochin M, Artemyev NO . (2006). Mutation R238E in transducin-alpha yields a GTPase and effector-deficient, but not dominant-negative, G-protein alpha-subunit. Mol Vis 12: 492–498.
Berman DM, Wilkie TM, Gilman AG . (1996). GAIP and RGS4 are GTPase-activating proteins for the Gi subfamily of G protein alpha subunits. Cell 86: 445–452.
Bourne HR . (1997). G proteins. The arginine finger strikes again. Nature 389: 673–674.
Casey PJ, Fong HK, Simon MI, Gilman AG . (1990). Gz, a guanine nucleotide-binding protein with unique biochemical properties. J Biol Chem 265: 2383–2390.
Coleman DE, Berghuis AM, Lee E, Linder ME, Gilman AG, Sprang SR . (1994). Structures of active conformations of Gi alpha 1 and the mechanism of GTP hydrolysis. Science 265: 1405–1412.
De Vries L, Mousli M, Wurmser A, Farquhar MG . (1995). GAIP, a protein that specifically interacts with the trimeric G protein G alpha i3, is a member of a protein family with a highly conserved core domain. Proc Natl Acad Sci USA 92: 11916–11920.
Doi M, Iwasaki K . (2002). Regulation of retrograde signaling at neuromuscular junctions by the novel C2 domain protein AEX-1. Neuron 33: 249–259.
Downward J . (2003). Targeting RAS signalling pathways in cancer therapy. Nat Rev Cancer 3: 11–22.
Farfel Z, Bourne HR, Iiri T . (1999). The expanding spectrum of G protein diseases. N Engl J Med 340: 1012–1020.
Forbes SA, Bhamra G, Bamford S, Dawson E, Kok C, Clements J et al. (2008). The Catalogue of Somatic Mutations in Cancer (COSMIC). Curr Protoc Hum Genet Chapter 10: Unit 10.11.
Garcia-Marcos M, Ghosh P, Farquhar MG . (2009). GIV is a nonreceptor GEF for G alpha i with a unique motif that regulates Akt signaling. Proc Natl Acad Sci USA 106: 3178–3183.
Garcia-Marcos M, Ghosh P, Ear J, Farquhar MG . (2010). A structural determinant that renders G alpha(i) sensitive to activation by GIV/girdin is required to promote cell migration. J Biol Chem 285: 12765–12777.
Ghosh P, Beas AO, Bornheimer SJ, Garcia-Marcos M, Forry EP, Johannson C et al. (2010). A G{alpha}i-GIV molecular complex binds epidermal growth factor receptor and determines whether cells migrate or proliferate. Mol Biol Cell 21: 2338–2354.
Ghosh P, Garcia-Marcos M, Bornheimer SJ, Farquhar MG . (2008). Activation of Galphai3 triggers cell migration via regulation of GIV. J Cell Biol 182: 381–393.
Grishina G, Berlot CH . (1998). Mutations at the domain interface of GSalpha impair receptor-mediated activation by altering receptor and guanine nucleotide binding. J Biol Chem 273: 15053–15060.
Higashijima T, Ferguson KM, Smigel MD, Gilman AG . (1987). The effect of GTP and Mg2+ on the GTPase activity and the fluorescent properties of Go. J Biol Chem 262: 757–761.
Iiri T, Farfel Z, Bourne HR . (1998). G-protein diseases furnish a model for the turn-on switch. Nature 394: 35–38.
Johnston CA, Taylor JP, Gao Y, Kimple AJ, Grigston JC, Chen JG et al. (2007). GTPase acceleration as the rate-limiting step in Arabidopsis G protein-coupled sugar signaling. Proc Natl Acad Sci USA 104: 17317–17322.
Kan Z, Jaiswal BS, Stinson J, Janakiraman V, Bhatt D, Stern HM et al. (2010). Diverse somatic mutation patterns and pathway alterations in human cancers. Nature 466: 869–873.
Kleuss C, Raw AS, Lee E, Sprang SR, Gilman AG . (1994). Mechanism of GTP hydrolysis by G-protein alpha subunits. Proc Natl Acad Sci USA 91: 9828–9831.
Kroll SD, Chen J, De Vivo M, Carty DJ, Buku A, Premont RT et al. (1992). The Q205LGo-alpha subunit expressed in NIH-3T3 cells induces transformation. J Biol Chem 267: 23183–23188.
Lamba S, Felicioni L, Buttitta F, Bleeker FE, Malatesta S, Corbo V et al. (2009). Mutational profile of GNAQQ209 in human tumors. PLoS One 4: e6833.
Landis CA, Masters SB, Spada A, Pace AM, Bourne HR, Vallar L . (1989). GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumours. Nature 340: 692–696.
Linder ME, Ewald DA, Miller RJ, Gilman AG . (1990). Purification and characterization of Go alpha and three types of Gi alpha after expression in Escherichia coli. J Biol Chem 265: 8243–8251.
Lyons J, Landis CA, Harsh G, Vallar L, Grunewald K, Feichtinger H et al. (1990). Two G protein oncogenes in human endocrine tumors. Science 249: 655–659.
Makita N, Sato J, Rondard P, Fukamachi H, Yuasa Y, Aldred MA et al. (2007). Human G(salpha) mutant causes pseudohypoparathyroidism type Ia/neonatal diarrhea, a potential cell-specific role of the palmitoylation cycle. Proc Natl Acad Sci USA 104: 17424–17429.
Marinissen MJ, Gutkind JS . (2001). G-protein-coupled receptors and signaling networks: emerging paradigms. Trends Pharmacol Sci 22: 368–376.
Mukhopadhyay S, Ross EM . (2002). Quench-flow kinetic measurement of individual reactions of G-protein-catalyzed GTPase cycle. Methods Enzymol 344: 350–369.
Pereira R, Cerione RA . (2005). A switch 3 point mutation in the alpha subunit of transducin yields a unique dominant-negative inhibitor. J Biol Chem 280: 35696–35703.
Radhika V, Dhanasekaran N . (2001). Transforming G proteins. Oncogene 20: 1607–1614.
Ram PT, Horvath CM, Iyengar R . (2000). Stat3-mediated transformation of NIH-3T3 cells by the constitutively active Q205L Galphao protein. Science 287: 142–144.
Sprang SR . (1997). G protein mechanisms: insights from structural analysis. Annu Rev Biochem 66: 639–678.
Sternweis PC, Robishaw JD . (1984). Isolation of two proteins with high affinity for guanine nucleotides from membranes of bovine brain. J Biol Chem 259: 13806–13813.
Van Raamsdonk CD, Bezrookove V, Green G, Bauer J, Gaugler L, O'Brien JM et al. (2009). Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi. Nature 457: 599–602.
Vara Prasad MV, Shore SK, Dhanasekaran N . (1994). Activated mutant of G alpha 13 induces Egr-1, c-fos, and transformation in NIH 3T3 cells. Oncogene 9: 2425–2429.
Voyno-Yasenetskaya TA, Pace AM, Bourne HR . (1994). Mutant alpha subunits of G12 and G13 proteins induce neoplastic transformation of Rat-1 fibroblasts. Oncogene 9: 2559–2565.
Warner DR, Weinstein LS . (1999). A mutation in the heterotrimeric stimulatory guanine nucleotide binding protein alpha-subunit with impaired receptor-mediated activation because of elevated GTPase activity. Proc Natl Acad Sci USA 96: 4268–4272.
Wong YH, Chan JS, Yung LY, Bourne HR . (1995). Mutant alpha subunit of Gz transforms Swiss 3T3 cells. Oncogene 10: 1927–1933.
Xu N, Bradley L, Ambdukar I, Gutkind JS . (1993). A mutant alpha subunit of G12 potentiates the eicosanoid pathway and is highly oncogenic in NIH 3T3 cells. Proc Natl Acad Sci USA 90: 6741–6745.
Xu N, Voyno-Yasenetskaya T, Gutkind JS . (1994). Potent transforming activity of the G13 alpha subunit defines a novel family of oncogenes. Biochem Biophys Res Commun 201: 603–609.
Zurita AR, Birnbaumer L . (2008). The same mutation in Gsalpha and transducin alpha reveals behavioral differences between these highly homologous G protein alpha-subunits. Proc Natl Acad Sci USA 105: 2363–2368.
Acknowledgements
This work was funded by NIH grants CA100768 and DKI7780 (to MGF). MGM was supported by a Susan G Komen postdoctoral fellowship KG080079 and PG by Burroughs Wellcome Fund and Research Scholar Award (American Gastroenterology Association FDN).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Garcia-Marcos, M., Ghosh, P. & Farquhar, M. Molecular basis of a novel oncogenic mutation in GNAO1. Oncogene 30, 2691–2696 (2011). https://doi.org/10.1038/onc.2010.645
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/onc.2010.645
Keywords
This article is cited by
-
An intronic GNAO1 variant leading to in-frame insertion cause movement disorder controlled by deep brain stimulation
neurogenetics (2022)
-
Dynamic regulation of GDP binding to G proteins revealed by magnetic field-dependent NMR relaxation analyses
Nature Communications (2017)
-
MicroRNA-31 controls G protein alpha-13 (GNA13) expression and cell invasion in breast cancer cells
Molecular Cancer (2015)
-
Upregulation of the microRNA cluster at the Dlk1-Dio3 locus in lung adenocarcinoma
Oncogene (2015)
-
The emerging mutational landscape of G proteins and G-protein-coupled receptors in cancer
Nature Reviews Cancer (2013)